英语文摘:Large-scale epidemic from XBB subvariant unlikely in short term: China CDC
BEIJING, Jan. 4 (Xinhua) -- The possibility of a large-scale epidemic caused by COVID-19 Omicron XBB subvariant is low in the short term in China, according to the Chinese Center for Disease Control and Prevention (China CDC).
Currently, BA.5.2 and BF.7, two sub-strains of Omicron variant BA.5, are the two dominating strains in the country, said a statement released by the China CDC on Wednesday.
It added that neutralizing antibodies from individuals infected with the two strains will remain at a relatively high level for about three months. These patients should have effective cross-protection against other Omicron variants, including XBB.
Xu Wenbo, director of the National Institute for Viral Disease Control and Prevention under the China CDC, said China detected BF.7, BQ.1, and XBB imports in the past three months, but BQ.1 and XBB subvariants have not developed into dominant subvariants in the country.
In terms of local cases, 16 local XBB infections were reported from October to December 2022, all of which were XBB.1, with only one case reported in December, according to the experts.
相关文章
- 英语文摘:China calls for avoiding politicization of COVID-19 pandemic: spokesperson
- 英语文摘:Xinhua Headlines: China, Philippines cement ties in new year
- 英语文摘:China to crack down on off-campus academic tutoring during winter vacation
- 英语文摘:China Focus: Chinese hospitals go all out to treat severe COVID-19 patients
- 英语文摘:China sees 52.7 mln domestic tourist trips over New Year holiday
- 英语文摘:Xi calls on Economic Daily to better tell China's economic development stories
- 英语文摘:Yearender-China Focus: Space mission records in 2022
- 英语文摘:To resume all-round dialogue with China, U.S. should take sincere actions: defense spokesperson
- 英语文摘:New high-speed railway operational in northwest China
- 英语文摘:China's top economic planner stresses sound development in 2023